Pretomanid in Adults With Hepatic Impairment

Stopped The TB hepatic pretomanid PK trial is closed to enrollment. There is no possibility of enrolling and completing the CSR before November 2024.

Conditions

• Tuberculosis

Interventions

• DRUG: PA-824

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)